SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-K/A - Annual report [Section 13 and 15(d), not S-K Item 405]: [Amend]
SEC Accession No. 0000819050-23-000044
Filing Date
2023-05-01
Accepted
2023-05-01 16:43:46
Documents
16
Period of Report
2022-12-31

Document Format Files

Seq Description Document Type Size
1 10-K/A frtx-20221231.htm   iXBRL 10-K/A 519441
2 EX-10.29 a2022123110kaex1029.htm EX-10.29 67773
3 EX-31.3 a2022123110k-apartiiiex313.htm EX-31.3 5585
4 EX-31.4 a2022123110k-apartiiiex314.htm EX-31.4 5249
  Complete submission text file 0000819050-23-000044.txt   894217

Data Files

Seq Description Document Type Size
5 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT frtx-20221231.xsd EX-101.SCH 2510
6 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT frtx-20221231_lab.xml EX-101.LAB 39849
7 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT frtx-20221231_pre.xml EX-101.PRE 22455
10 EXTRACTED XBRL INSTANCE DOCUMENT frtx-20221231_htm.xml XML 18881
Mailing Address 5777 CENTRAL AVENUE SUITE 102 BOULDER CO 80301
Business Address 5777 CENTRAL AVENUE SUITE 102 BOULDER CO 80301 (720) 505-4755
Fresh Tracks Therapeutics, Inc. (Filer) CIK: 0000819050 (see all company filings)

IRS No.: 930948554 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K/A | Act: 34 | File No.: 000-21088 | Film No.: 23874461
SIC: 2836 Biological Products, (No Diagnostic Substances)